Myfortic
Mycophenolic acid · Novartis Pharmaceuticals Corporation
CANCER MEDICINE · PRESCRIPTION ONLY (USA)Myfortic ingredients
| Active ingredient | Strength |
|---|---|
| Mycophenolate Sodium | 180 mg/1, 360 mg/1 |
What Myfortic is used for
Myfortic is a cancer medicine (antimetabolite immunosuppressant). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Myfortic
- Generic name
- Mycophenolic acid
- Made by
- Novartis Pharmaceuticals Corporation
- Forms
- Tablet, Delayed Release
- Given
- Oral
- Drug class
- Antimetabolite Immunosuppressant
- FDA approval
- New drug application (NDA) NDA050791
- On the US market since
- 2004
Official information
- Myfortic prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Mycophenolic acid)
In India
- Mycophenolate sodium: 57 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Myfortic?
Myfortic (Mycophenolic acid) is a cancer medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.
What are the ingredients of Myfortic?
Myfortic contains Mycophenolate Sodium (180 mg/1, 360 mg/1).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA